Pharma and Healthcare
Encyclopedia of pharmaceutical and healthcare terms covering the full drug development and commercialization lifecycle, medical devices, intellectual property, and licensing structures.
Biosimilars
Quote
“Biosimilars will do for biologics what generics did for small-molecule drugs.”
— Leah Christl
Definition: Biosimilars are biological medical products that are highly similar to an already approved reference biologic drug, with no clinically meaningful differences in terms of safety, purity, or potency. Unlike generic versions of small-molecule drugs, biosimilars cannot be exact copies because biological drugs are made from living organisms and are structurally complex. The development and approval of biosimilars requires extensive comparative analytical, preclinical, and clinical studies to demonstrate similarity to the reference product. Biosimilars offer more affordable alternatives to expensive biologic therapies.
In context: CSL Limited (CSL.AX, an Asia-Pacific equity index) “manufactures, markets, and distributes plasma products, gene therapies, and recombinants” in its CSL Behring segment. AbbVie (ABBV, a US equity index) develops biopharmaceutical products where biosimilar competition is a significant market factor.
Real-world example: When the patent on a blockbuster biologic drug for rheumatoid arthritis expires, other pharmaceutical companies can develop biosimilar versions that are highly similar in efficacy and safety, often priced 20-30% lower, making the treatment more accessible to patients.
Related terms: Clinical Trials, Regulatory Approval, Recombinant Therapies, Generic Drugs
CDMO (Contract Development and Manufacturing Organization)
Quote
“Not every innovator needs to be a manufacturer — the best ideas can be built by the best builders.”
— Chris Chen
Definition: A CDMO is a company that provides comprehensive services for the development and manufacturing of pharmaceutical and biopharmaceutical products on a contract basis. CDMOs support drug companies by handling some or all of the steps needed to bring a drug from development through to large-scale commercial production. They offer expertise in process development, formulation, analytical testing, clinical trial material manufacturing, and commercial-scale production. Using a CDMO allows pharmaceutical companies to avoid the enormous capital costs of building their own manufacturing facilities.
In context: WuXi Biologics (2269.HK, an Asia-Pacific equity index) provides “end-to-end solutions and services for biologics discovery, development, and manufacturing” through its “contract research, development, and manufacturing organization platforms.” It also engages in “vaccine contract development and manufacturing organization (CDMO) and related business.”
Real-world example: A small biotech company discovers a promising antibody therapy but lacks manufacturing capabilities. It contracts with a CDMO like WuXi Biologics to develop the manufacturing process, produce clinical trial materials, and eventually scale up to commercial production.
Related terms: Clinical Trials, Biosimilars, Out-Licensing, Recombinant Therapies
Clinical Trials
Quote
“Without clinical trials, there can be no better treatments, no prevention strategies, and no cures.”
— Janet Woodcock
Definition: Clinical trials are research studies performed on human volunteers to evaluate the safety and efficacy of new medical treatments, drugs, devices, or diagnostic procedures. They follow a rigorous multi-phase process: Phase I tests safety and dosing on a small group; Phase II evaluates efficacy and side effects on a larger group; Phase III confirms effectiveness on large populations and monitors adverse reactions; and Phase IV occurs after regulatory approval to monitor long-term effects. Clinical trials are essential for obtaining regulatory approval from agencies such as the FDA (US) or EMA (Europe) before a new treatment can be marketed.
In context: argenx SE (ARGX.BR, a European equity index) develops “various therapies for the treatment of autoimmune diseases” with multiple drug candidates in various clinical stages. Daiichi Sankyo (4568.T, an Asia-Pacific equity index) develops and tests numerous pharmaceutical compounds for oncology and cardiovascular conditions. Sanofi (SAN.PA, a European equity index) has collaboration agreements to “develop up to 15 novel small-molecule for oncology and immunology.”
Real-world example: A pharmaceutical company enrolls 3,000 patients across 200 hospitals in a Phase III clinical trial for a new diabetes drug. Half the patients receive the new drug, and half receive a placebo. After two years, the results show the new drug significantly lowers blood sugar levels with acceptable side effects, allowing the company to apply for FDA approval.
Related terms: FDA Approval, Regulatory Approval, Biosimilars, In-Licensing Agreement
FDA Approval
Quote
“The FDA is the gatekeeper between science and the patient — its approval is the final exam.”
— Margaret Hamburg
Definition: FDA approval refers to the authorization granted by the U.S. Food and Drug Administration for a drug, biologic, medical device, or other regulated product to be marketed and sold in the United States. The FDA evaluates scientific data from clinical trials to determine whether a product’s benefits outweigh its risks. For drugs, the approval process involves review of a New Drug Application (NDA) or Biologics License Application (BLA) and typically takes 10-12 months following submission. FDA approval is a critical milestone for pharmaceutical companies as it unlocks access to the world’s largest pharmaceutical market.
In context: argenx SE (ARGX.BR, a European equity index) has products approved to “treat generalized myasthenia gravis.” Eli Lilly (LLY, a US equity index) has obtained approval for treatments like “Mounjaro” and “Zepbound.” AbbVie (ABBV, a US equity index) has multiple approved products including “Skyrizi” and “Rinvoq.”
Real-world example: A pharmaceutical company submits a New Drug Application to the FDA containing data from clinical trials involving 10,000 patients. FDA scientists review the safety and efficacy data over 10-12 months. If the drug is found to be safe and effective, the FDA issues an approval letter allowing the company to begin selling the drug in the United States.
Related terms: Regulatory Approval, Clinical Trials, Patent
Generic Drugs
Quote
“Generic drugs are one of the greatest success stories in public health.”
— Scott Gottlieb
Definition: Generic drugs are pharmaceutical products that are equivalent to brand-name drugs in dosage form, strength, route of administration, quality, performance, and intended use. They are manufactured and sold after the brand-name drug’s patent protection has expired, allowing other manufacturers to produce and sell the same formulation at significantly lower prices. Generic drugs must meet the same regulatory standards as brand-name drugs and undergo abbreviated approval processes to demonstrate bioequivalence. They play a crucial role in making healthcare more affordable and accessible.
In context: Bayer (BAYN.DE, a European equity index) provides pharmaceutical products that face generic competition, offering both “prescription products” and “nonprescription over-the-counter medicines.” Takeda Pharmaceutical (4502.T, an Asia-Pacific equity index) operates in therapeutic areas where generic competition is a significant market factor.
Real-world example: When the patent on a blockbuster cholesterol-lowering drug expires, multiple generic manufacturers begin producing the same drug at one-fifth the original price. A patient who previously paid USD 200/month for the brand-name version can now get the same medication for USD 40/month.
Related terms: Biosimilars, Clinical Trials, Regulatory Approval, Patent
In-Licensing Agreement
Quote
“You do not need to invent everything yourself — the smartest companies know when to license from others.”
— Henry Chesbrough, Open Innovation (2003)
Definition: An in-licensing agreement is a contractual arrangement in which a company acquires the rights to develop, manufacture, or sell a product, technology, or intellectual property from another company. This is common in the pharmaceutical and technology industries, where one company may have discovered a promising drug or technology but lacks the resources, manufacturing capabilities, or market access to bring it to market. The licensee typically pays upfront fees, milestone payments, and royalties on future sales to the licensor.
In context: Takeda Pharmaceutical (4502.T, an Asia-Pacific equity index) “has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada.” Sanofi (SAN.PA, a European equity index) has “collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology.” Eli Lilly (LLY, a US equity index) has “license agreements with Almirall, S.A. for Ebglyss.”
Real-world example: A mid-sized Japanese pharmaceutical company in-licenses a promising cancer therapy from a small US biotech startup. The Japanese company pays USD 50 million upfront, commits to paying up to USD 500 million in development milestones, and agrees to pay 10% royalties on net sales. In return, it obtains exclusive rights to develop and commercialize the drug in Asia.
Related terms: Out-Licensing, Intellectual Property (IP), Patent, Clinical Trials, Royalties
Intellectual Property (IP)
Quote
“Intellectual property is the oil of the 21st century.”
— Mark Getty
Definition: Intellectual property refers to creations of the mind that are legally protected from unauthorized use by others. IP includes patents (protecting inventions), trademarks (protecting brand names and logos), copyrights (protecting creative works), and trade secrets (protecting confidential business information). IP protection incentivizes innovation by granting creators exclusive rights to use and commercialize their inventions and creations for a specified period. In the business world, IP can represent significant value, forming the basis for licensing agreements, royalties, and competitive advantage.
In context: Apple Inc. (AAPL, a US equity index) “licenses its intellectual property.” Nintendo Co. (7974.T, an Asia-Pacific equity index) “offers develop IP, including video content and mobile apps.” CSL Limited (CSL.AX, an Asia-Pacific equity index) “licenses CSL intellectual property.” Ferrari (RACE.MI, a European equity index) “licenses its Ferrari brand to various producers and retailers of luxury and lifestyle goods.”
Real-world example: A pharmaceutical company holds a patent on a new diabetes drug, giving it exclusive rights to manufacture and sell the drug for 20 years. During this time, no other company can produce the same drug, allowing the patent holder to charge higher prices and recoup its research and development investment.
Related terms: Patent, In-Licensing Agreement, Out-Licensing, Royalties
Medical Devices
Quote
“The best medical device is one the physician forgets is there because it works so well.”
— Earl Bakken, founder of Medtronic
Definition: Medical devices are instruments, apparatus, machines, implants, or diagnostic tools used in the diagnosis, prevention, monitoring, or treatment of medical conditions. The medical device industry ranges from simple products like bandages and syringes to complex technologies like MRI scanners, robotic surgical systems, and implantable cardiac devices. Medical devices must meet stringent regulatory requirements and undergo rigorous testing before they can be marketed. The industry is characterized by continuous innovation, high barriers to entry, and strong intellectual property protection.
In context: Johnson & Johnson (JNJ, a US equity index) through its MedTech segment provides “products used in the surgery, orthopedic, cardiovascular, and vision fields” including “robotic surgical procedures.” HOYA Corporation (7741.T, an Asia-Pacific equity index) offers “medical endoscopes; intraocular lenses; laparoscopic surgical instruments.” Siemens AG (SIE.DE, a European equity index) through Siemens Healthineers “develops, manufactures, and sells various diagnostic and therapeutic products.”
Real-world example: A hospital purchases a robotic surgery system from a medical device company. The system enables surgeons to perform minimally invasive procedures with greater precision, smaller incisions, and faster patient recovery. The device costs USD 2 million, and the hospital also pays for instruments and annual maintenance contracts.
Related terms: Clinical Trials, Regulatory Approval, Patent
Out-Licensing
Quote
“Open innovation means your most valuable ideas may reach patients faster through someone else’s hands.”
— Henry Chesbrough, Open Innovation (2003)
Definition: Out-licensing is the process by which a company grants the rights to its intellectual property, technology, or product to another company for development, manufacturing, or commercialization. The licensor typically receives upfront payments, milestone payments, and ongoing royalties. Out-licensing is common in the pharmaceutical industry, where a company that has developed a promising drug candidate may not have the resources or geographic reach to commercialize it globally, so it licenses the rights for specific markets or indications to a larger partner.
In context: Takeda Pharmaceutical (4502.T, an Asia-Pacific equity index) “engages in the…out-licensing of pharmaceutical products.” CSL Limited (CSL.AX, an Asia-Pacific equity index) “licenses CSL intellectual property.” Exxon Mobil (XOM, a US equity index) offers “licensing services.”
Real-world example: A Japanese pharmaceutical company develops a promising drug for a rare disease and out-licenses the commercialization rights for North America and Europe to a large US pharmaceutical company. The Japanese company receives USD 100 million upfront, potential milestone payments of USD 300 million, and a 15% royalty on net sales.
Related terms: In-Licensing Agreement, Intellectual Property (IP), Patent, Royalties
Patent
Quote
“The patent system added the fuel of interest to the fire of genius.”
— Abraham Lincoln
Definition: A patent is a legal right granted by a government to an inventor, giving the inventor exclusive rights to make, use, sell, and license their invention for a specific period (typically 20 years from the filing date). Patents protect novel, non-obvious, and useful inventions, including products, processes, and technologies. In exchange for the exclusive rights, the inventor must publicly disclose the details of the invention, enabling others to build on the knowledge after the patent expires. Patents are particularly important in the pharmaceutical, technology, and manufacturing industries.
In context: AbbVie (ABBV, a US equity index) develops numerous patented pharmaceutical products. Eli Lilly (LLY, a US equity index) holds patents on drugs like Mounjaro and Zepbound. Infineon Technologies (IFX.DE, a European equity index) develops patented semiconductor technologies. ASML (ASML.AS, a European equity index) holds patents on its extreme ultraviolet lithography technology.
Real-world example: A biotech company invents a new method for delivering medication through the skin using microscopic needles. It files a patent application describing the invention in detail. Once granted, the patent gives the company 20 years of exclusive rights to commercialize the technology, preventing competitors from copying it without a license.
Related terms: Intellectual Property (IP), Generic Drugs, Regulatory Approval, In-Licensing Agreement
Recombinant Therapies
Quote
“Genetic engineering will transform medicine more profoundly than any technology since antibiotics.”
— Paul Berg
Definition: Recombinant therapies are medical treatments derived from recombinant DNA technology, in which genetic material from different sources is combined to create new genetic sequences. This technology is used to produce proteins, hormones, and other biological molecules in large quantities for therapeutic use. Common examples include recombinant insulin for diabetes, recombinant growth hormone, and recombinant clotting factors for hemophilia. Recombinant technology has enabled the production of purer, more consistent, and more scalable biological therapies than those derived from natural sources.
In context: CSL Limited (CSL.AX, an Asia-Pacific equity index) through CSL Behring “manufactures, markets, and distributes plasma products, gene therapies, and recombinants.” Takeda Pharmaceutical (4502.T, an Asia-Pacific equity index) offers “Recombinate” as one of its products for hemophilia treatment.
Real-world example: A patient with hemophilia A receives infusions of recombinant Factor VIII, a clotting protein produced in a laboratory using recombinant DNA technology. Unlike the older approach of extracting the protein from donated blood (which carried risks of contamination), the recombinant version is produced in engineered cells, ensuring consistent quality and safety.
Related terms: Biosimilars, Clinical Trials, Patent, CDMO
Regulatory Approval
Definition: Regulatory approval is the formal authorization granted by a government agency that a product, service, or activity meets established safety, quality, and legal requirements. In the pharmaceutical industry, regulatory approval from agencies such as the FDA (US), EMA (Europe), or PMDA (Japan) is required before a new drug can be sold. In financial services, regulatory approval may be needed for bank mergers, new financial products, or market entry. The regulatory approval process can be lengthy and expensive, but it protects consumers and maintains market integrity.
In context: argenx SE (ARGX.BR, a European equity index) has products approved to “treat generalized myasthenia gravis” and is developing additional therapies requiring regulatory approval. Eli Lilly (LLY, a US equity index) has obtained approval for treatments like “Mounjaro” and “Zepbound.” AbbVie (ABBV, a US equity index) has multiple approved products including “Skyrizi” and “Rinvoq.”
Real-world example: A pharmaceutical company submits a New Drug Application to the FDA containing data from clinical trials involving 10,000 patients. FDA scientists review the safety and efficacy data over 10-12 months. If the drug is found to be safe and effective, the FDA issues an approval letter allowing the company to begin selling the drug in the United States.
Related terms: Clinical Trials, Patent, FDA Approval, Biosimilars
Aftermarket
Quote
“The sale of the product is just the beginning — the real relationship is built through service.”
— Harvey Mackay
Definition: The aftermarket refers to the secondary market for parts, accessories, services, and upgrades for a product after its initial sale. In industries like automotive, aerospace, and heavy machinery, the aftermarket can be more profitable than the initial product sale because equipment owners need ongoing maintenance, spare parts, and performance upgrades throughout the product’s operational life. Companies that build durable goods often derive a significant share of their revenue from aftermarket activities, creating a recurring revenue stream.
In context: Rheinmetall AG (RHM.DE, a European equity index) “also engages in the aftermarket activities” for its Power Systems segment, which provides mobility solutions and control technologies. Similarly, RTX Corporation (RTX, a US equity index) through its Collins Aerospace segment provides “spare parts, overhaul and repair, engineering and technical support” as aftermarket services.
Real-world example: After purchasing a commercial jet engine, an airline continues to buy replacement turbine blades, lubricants, and scheduled overhaul services from the engine manufacturer for 20-30 years — this ongoing business is the aftermarket.
Related terms: Maintenance Repair and Overhaul (MRO), OEM (Original Equipment Manufacturer)
Compliance
Definition: Compliance refers to the process of adhering to laws, regulations, guidelines, and internal policies that govern a company’s operations. In the financial sector, compliance is particularly critical because of extensive regulatory requirements designed to protect consumers, prevent fraud, combat money laundering, and maintain market integrity. Compliance departments within financial institutions are responsible for monitoring adherence to regulations, implementing policies, conducting training, and reporting to regulatory authorities. Non-compliance can result in severe penalties, including fines, license revocations, and reputational damage.
In context: Wolters Kluwer (WKL.AS, a European equity index) operates a “Financial & Corporate Compliance” segment that “offers solutions for legal entity and banking product compliance.” Its Legal & Regulatory segment serves “legal and compliance professionals in law firms, corporate legal departments.” Broadcom (AVGO, a US equity index) offers “cybersecurity & compliance management” for mainframe systems.
Real-world example: A bank’s compliance department monitors all customer transactions above USD 10,000, files Suspicious Activity Reports (SARs) when patterns suggest money laundering, conducts annual anti-money laundering training for all employees, and ensures the bank meets Know Your Customer (KYC) requirements for every new account opened.
Related terms: Regulatory Approval, Risk Management
Concessions
Definition: A concession is a contractual right granted by a government or other entity to a private company to operate, maintain, and develop a specific infrastructure asset or public service for a defined period. In exchange, the concessionaire typically invests in maintaining and improving the infrastructure and collects revenues from users (such as tolls for highways or landing fees for airports). At the end of the concession period, the asset reverts to the government. Concession-based business models are common in transportation infrastructure, utilities, and public services.
In context: Vinci SA (DG.PA, a European equity index) through its Concessions segment “operates motorways, autoroutes, airports, highways, railways, and stadiums.” The company has a significant concessions business alongside its energy and construction operations.
Real-world example: A French construction company wins a 40-year concession to operate a 200-kilometer motorway. The company invests EUR 2 billion to build the road, then collects toll revenues from drivers for the concession period. After 40 years, the motorway reverts to the French government.
Related terms: Project Finance, Franchise
Distributors
Quote
“Getting the product to the customer is half the battle — distribution is strategy.”
— Jeff Bezos
Definition: Distributors are intermediary entities that purchase products from manufacturers and resell them to retailers, businesses, or directly to consumers. Distributors add value by providing logistics, warehousing, marketing, credit, and after-sales service. They serve as a critical link in the supply chain, enabling manufacturers to reach broad markets without building their own extensive sales and delivery infrastructure. Distribution networks can be exclusive (one distributor per region) or non-exclusive (multiple distributors compete in the same area).
In context: Coca-Cola (KO, a US equity index) “operates through a network of independent bottling partners, distributors, wholesalers, and retailers.” PepsiCo (PEP, a US equity index) serves “wholesale and other distributors, foodservice customers” through various distribution networks. Bayer (BAYN.DE, a European equity index) “distributes its products through wholesalers, pharmacies and pharmacy chains.”
Real-world example: Coca-Cola does not sell directly to every corner store. Instead, an independent bottler/distributor in a specific region buys concentrated syrup from Coca-Cola, manufactures the finished beverage, and delivers it to thousands of retail stores, restaurants, and vending machines in its territory.
Related terms: Supply Chain, Resellers, Logistics
Fleet Management
Quote
“Data from the fleet tells you more about your operations than any spreadsheet ever could.”
— Jim Heppelmann
Definition: Fleet management is the administration of a company’s vehicle fleet, including acquisition, maintenance, fuel management, driver management, insurance, and disposal. Modern fleet management increasingly relies on telematics, GPS tracking, data analytics, and digital platforms to optimize routing, reduce costs, monitor driver behavior, ensure regulatory compliance, and manage vehicle lifecycles. Fleet management can apply to commercial vehicles, corporate car fleets, rental fleets, and specialized vehicle fleets.
In context: Mercedes-Benz Group (MBG.DE, a European equity index) provides “fleet management” services along with financing, leasing, and insurance. BMW (BMW.DE, a European equity index) offers “vehicle fleet financing services for corporate car fleets under the Alphabet brand.” Caterpillar (CAT, a US equity index) provides “fleet management, equipment management analytics, autonomous machine capabilities.”
Real-world example: A delivery company with 500 vans uses a fleet management platform to track each vehicle’s location in real time, optimize delivery routes to reduce fuel consumption, schedule preventive maintenance based on mileage data, and monitor driver behavior to reduce accidents and insurance costs.
Related terms: Leasing, Logistics
Franchise
Definition: A franchise is a business arrangement in which a company (the franchisor) grants another party (the franchisee) the right to operate a business using the franchisor’s brand name, trademarks, proprietary knowledge, and business systems. The franchisee typically pays an upfront franchise fee and ongoing royalties to the franchisor. Franchising enables rapid expansion with lower capital requirements for the franchisor while providing franchisees with a proven business model, brand recognition, and operational support. It is a common model in fast food, retail, hotels, and automotive dealerships.
In context: McDonald’s Corporation (MCD, a US equity index) “owns, operates, and franchises restaurants under the McDonald’s brand” through “conventional franchise, developmental license, or affiliate” structures. adidas AG (ADS.DE, a European equity index) sells through “mono-branded franchise stores.” Ferrari (RACE.MI, a European equity index) “operates franchised and owned Ferrari stores.”
Real-world example: An entrepreneur pays McDonald’s a franchise fee of USD 45,000 and agrees to pay 4% of monthly sales as royalties. In return, the franchisee receives the right to operate a McDonald’s restaurant, access to the brand and marketing materials, training programs, supply chain support, and ongoing operational guidance.
Related terms: Intellectual Property (IP), Royalties, Concessions
Goodwill
Definition: Goodwill is an intangible asset that arises when one company acquires another for more than the fair value of its identifiable net assets. It represents the premium paid for elements such as brand reputation, customer relationships, proprietary technology, employee expertise, and market position that cannot be separately identified and valued. Under accounting standards (IFRS and US GAAP), goodwill must be tested annually for impairment and written down if its carrying value exceeds its recoverable amount. Goodwill is a common item on the balance sheets of companies that grow through acquisitions.
In context: Many companies across the example indices carry significant goodwill on their balance sheets following acquisitions. Companies like AbbVie (ABBV, a US equity index) and other large pharmaceutical and technology acquirers record substantial goodwill after paying acquisition premiums for innovative businesses.
Real-world example: A technology company acquires a cloud software startup for USD 2 billion. The startup’s identifiable net assets (servers, software, receivables less liabilities) are worth USD 500 million. The remaining USD 1.5 billion paid above fair value is recorded as goodwill, representing the startup’s brand, customer base, and engineering talent.
Related terms: Mergers and Acquisitions (M&A), Intellectual Property (IP)
Licensing
Definition: Licensing is a business arrangement in which the owner of intellectual property (IP) — such as a patent, trademark, copyright, or technology — grants permission to another party to use that IP in exchange for compensation, typically in the form of royalties, license fees, or other financial consideration. Licensing enables IP owners to generate revenue from their innovations without having to manufacture or market products themselves, and it allows licensees to access proven technologies, brands, or content without developing them from scratch.
In context: Ferrari (RACE.MI, a European equity index) “licenses its Ferrari brand to various producers and retailers of luxury and lifestyle goods.” Apple Inc. (AAPL, a US equity index) “licenses its intellectual property.” Deutsche Boerse (DB1.DE, a European equity index) provides “index licensing” services. Exxon Mobil (XOM, a US equity index) offers “licensing services” in its Energy Products segment.
Real-world example: Ferrari licenses its brand name to a luxury watchmaker, allowing the watchmaker to produce and sell “Ferrari” branded watches. Ferrari receives a royalty on each watch sold without bearing any manufacturing or distribution costs, while the watchmaker benefits from Ferrari’s prestigious brand recognition.
Related terms: Intellectual Property (IP), Franchise, In-Licensing Agreement, Patent
Logistics
Definition: Logistics is the process of planning, implementing, and controlling the efficient, effective flow and storage of goods, services, and related information from the point of origin to the point of consumption. It encompasses transportation, warehousing, inventory management, order fulfillment, and distribution. Logistics is a critical function in supply chain management, and companies invest heavily in logistics to reduce costs, improve delivery speed, and enhance customer satisfaction. Modern logistics increasingly leverages technology such as GPS tracking, AI-driven route optimization, and automated warehouses.
In context: Deutsche Post (DHL.DE, a European equity index) provides “customized logistics services and supply chain solutions.” Uber Technologies (UBER, a US equity index) through its Freight segment “manages transportation and logistics networks.” ITOCHU Corporation (8001.T, an Asia-Pacific equity index) offers “BPO…and insurance brokerage services” alongside its logistics operations. Berkshire Hathaway (BRK-B, a US equity index) provides “logistics services.”
Real-world example: An online retailer uses a logistics company to store products in warehouses near major cities. When a customer places an order, the logistics system automatically selects the nearest warehouse, picks and packs the item, and arranges delivery via the fastest and most cost-effective route, achieving same-day or next-day delivery.
Related terms: Supply Chain, Fleet Management, Procurement
Maintenance Repair and Overhaul (MRO)
Quote
“Safety is not an option in aviation — maintenance is the price of keeping aircraft in the sky.”
— Robert Crandall
Definition: Maintenance, Repair, and Overhaul (MRO) refers to the comprehensive range of activities required to keep complex equipment and machinery in safe, operational condition throughout its useful life. In the aerospace and defense industries, MRO includes scheduled inspections, component repairs, engine overhauls, structural modifications, and compliance with regulatory airworthiness requirements. MRO services represent a significant and recurring revenue stream for equipment manufacturers, as the installed base of engines, aircraft, and other complex systems requires continuous maintenance over decades of operation.
In context: Safran SA (SAF.PA, a European equity index) provides “maintenance, repair, and overhaul (MRO) services, as well as sells spare parts” for its aerospace propulsion products. General Electric (GE, a US equity index) provides “maintenance, repair, and overhaul (MRO) services of jet engines and sale of spare parts.” RTX Corporation (RTX, a US equity index) through Pratt & Whitney provides “aftermarket maintenance, repair, and overhaul services.”
Real-world example: After a commercial jet engine accumulates 20,000 flight hours, the airline sends it to the manufacturer’s MRO facility for a scheduled overhaul. Technicians disassemble the engine, inspect every component, replace worn parts, reassemble and test it, and return it to service — a process that takes about two months and costs several million dollars.
Related terms: Aftermarket, OEM (Original Equipment Manufacturer)
OEM (Original Equipment Manufacturer)
Definition: An Original Equipment Manufacturer (OEM) is a company that produces parts or equipment that are marketed and sold by another company under its own brand name. In practice, the term has evolved to also refer to companies that manufacture complete end products (such as Dell or HP in computing, or Toyota in automotive). OEM relationships are common in manufacturing industries where specialized component makers supply parts to final product assemblers. OEM sales typically involve large volume contracts with specific quality requirements and design specifications.
In context: BASF SE (BAS.DE, a European equity index) provides “automotive OEM and refinish coatings” through its Surface Technologies segment. Applied Materials (AMAT, a US equity index) “serves manufacturers of semiconductor wafers and chips.” AMD (AMD, a US equity index) serves “original equipment and design manufacturers, public cloud service providers.” Intel (INTC, a US equity index) “sells its products through…OEM partners.”
Real-world example: BASF produces paint and coatings that car manufacturers like BMW use to paint their vehicles on the assembly line. BASF is the OEM coatings supplier, and its paint becomes part of the finished BMW vehicle. When the car later needs repainting after an accident, BMW-authorized body shops use BASF’s refinish coatings.
Related terms: Aftermarket, Supply Chain, Procurement
Operating Lease
Definition: An operating lease is a contract in which the lessee rents an asset (such as equipment, vehicles, or real estate) for a period shorter than the asset’s economic life. The lessee does not assume ownership risks or rewards; the lessor retains the asset on its balance sheet. Under IFRS 16 and ASC 842, even operating leases must now be recognized on the lessee’s balance sheet as a right-of-use asset and lease liability. Operating leases are popular for assets that depreciate quickly or need frequent replacement, as they allow lessees to use assets without long-term ownership obligations.
In context: BMW (BMW.DE, a European equity index) provides “leasing that include insurance and service products.” Tesla (TSLA, a US equity index) offers operating “leases” for its vehicles and solar energy systems. Seven & i Holdings (3382.T, an Asia-Pacific equity index) is involved in “leasing” businesses.
Real-world example: An airline signs an operating lease for 10 Airbus A320s with a 7-year term. At the end of the lease, the airline returns the aircraft to the lessor without any purchase obligation. This lets the airline update its fleet without the capital burden of ownership or the risk of holding aging aircraft on its balance sheet.
Related terms: Leasing, Fleet Management
Precious Metals
Quote
“Gold is money. Everything else is credit.”
— J.P. Morgan
Definition: Precious metals are rare, naturally occurring metallic elements of high economic value, including gold, silver, platinum, and palladium. They are valued for their rarity, durability, luster, and diverse industrial applications. Gold and silver have historically served as stores of value and currency. Platinum and palladium are critical for automotive catalytic converters, industrial processes, and jewelry. Precious metals are traded on commodity exchanges and OTC markets, and they serve as investment vehicles (physical bullion, ETFs, futures) and industrial inputs.
In context: BHP Group (BHP.AX, an Asia-Pacific equity index) and other diversified miners produce precious metals alongside base metals. Hong Kong Exchanges and Clearing (0388.HK, an Asia-Pacific equity index) offers “base, ferrous, and precious metals futures and options contracts.” Deutsche Boerse (DB1.DE, a European equity index) provides trading infrastructure for precious metals derivatives.
Real-world example: An investor purchases 10 ounces of gold at USD 2,000 per ounce as a hedge against inflation and currency depreciation. The gold is stored in a secure vault. Two years later, with gold at USD 2,400 per ounce, the investor sells for a USD 4,000 gain.
Related terms: Commodity Trading, Open-Pit Mining
Procurement
Quote
“Every dollar saved in procurement is a dollar straight to the bottom line.”
— Tim Cook
Definition: Procurement is the process of finding, acquiring, and buying goods, services, or works from an external source, often through a competitive bidding process. It encompasses the entire process from identifying needs, sourcing suppliers, negotiating contracts, purchasing, receiving goods, and paying suppliers. Strategic procurement aims to optimize costs, quality, and supply reliability while managing risks in the supply chain. Modern procurement increasingly uses digital platforms, e-procurement systems, and AI-driven analytics.
In context: SAP SE (SAP.DE, a European equity index) provides “SAP S/4HANA that provides software capabilities for…procurement.” Woolworths Group (WOW.AX, an Asia-Pacific equity index) engages in “procurement and distribution of food and related products.” Xiaomi Corporation (1810.HK, an Asia-Pacific equity index) is involved in “procurement and sales of smartphones, ecosystem partners’ products and spare parts.”
Real-world example: A hospital uses a procurement platform to source medical supplies. The system sends requests for proposals to approved suppliers, compares bids on price, quality, and delivery time, and automatically generates purchase orders for the winning suppliers. The platform tracks deliveries, manages inventory levels, and processes payments.
Related terms: Supply Chain, Logistics
Resellers
Definition: Resellers are businesses that purchase products from manufacturers, distributors, or other suppliers and sell them to end customers, often adding value through services such as customization, integration, support, and consultation. In the technology industry, value-added resellers (VARs) play an important role by combining hardware, software, and services into complete solutions for customers. Resellers provide manufacturers with broader market coverage and customer relationships.
In context: Deutsche Telekom (DTE.DE, a European equity index) “sells mobile services to resellers and to companies that buys and markets network services to third parties.” Intel (INTC, a US equity index) sells products through “distributors, resellers, retailers, and OEM partners.” Cisco Systems (CSCO, a US equity index) “sells its products and services directly, through systems integrators, service providers, resellers, and distributors.”
Real-world example: A technology reseller purchases 500 Dell servers and combines them with networking equipment, storage systems, and management software to create a complete data center solution for a hospital. The reseller installs the equipment, migrates the hospital’s data, and provides ongoing technical support.
Related terms: Distributors, OEM (Original Equipment Manufacturer), Supply Chain
Royalties
Definition: Royalties are payments made by one party (the licensee) to another (the licensor) for the ongoing use of an asset, typically intellectual property such as patents, trademarks, copyrights, franchises, or natural resources. Royalties are usually calculated as a percentage of revenue or profits generated from the use of the licensed asset, or as a per-unit fee. They represent a way for IP owners to monetize their creations over time and for licensees to access valuable assets without the cost and risk of developing them independently.
In context: Ferrari (RACE.MI, a European equity index) “licenses its Ferrari brand to various producers and retailers of luxury and lifestyle goods” earning royalties. Banco Santander (SAN.MC, a European equity index) is involved in licensing and royalty-bearing activities.
Real-world example: A fashion house licenses its brand name to a fragrance company that produces and sells perfumes bearing the fashion brand. The fashion house receives a 10% royalty on all perfume sales, earning EUR 50 million annually without any involvement in manufacturing or distribution.
Related terms: Licensing, Intellectual Property (IP), Franchise, Patent
Supply Chain
Definition: A supply chain is the entire network of entities, resources, activities, and technologies involved in the creation, production, and delivery of a product from raw materials to the end consumer. It includes sourcing raw materials, manufacturing, warehousing, transportation, distribution, and retail. Supply chain management (SCM) involves coordinating and optimizing these activities to minimize costs, improve quality, reduce lead times, and enhance customer satisfaction. Modern supply chains increasingly leverage digital technologies for visibility, predictive analytics, and automation.
In context: SAP SE (SAP.DE, a European equity index) provides software for “supply chain and asset management.” Deutsche Post (DHL.DE, a European equity index) delivers “supply chain solutions.” Sumitomo Mitsui Financial Group (8316.T, an Asia-Pacific equity index) provides “supply chain finance” services. Woolworths Group (WOW.AX, an Asia-Pacific equity index) provides “supply chain services to business customers.”
Real-world example: A smartphone manufacturer’s supply chain spans dozens of countries: rare earth minerals mined in Africa, semiconductors fabricated in Taiwan, screens manufactured in South Korea, final assembly in China, and distribution to retail stores worldwide. Supply chain management software coordinates all these activities, tracking every component from mine to consumer.
Related terms: Logistics, Procurement, OEM (Original Equipment Manufacturer), Trade Finance